1145 related articles for article (PubMed ID: 1909705)
1. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
2. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.
Waldstreicher J; Santoro NF; Hall JE; Filicori M; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):165-72. PubMed ID: 2961784
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
4. The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates.
Fauser BC; Pache TD; Hop WC; de Jong FH; Dahl KD
Clin Endocrinol (Oxf); 1992 Nov; 37(5):445-52. PubMed ID: 1486695
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea.
Burger CW; Korsen T; van Kessel H; van Dop PA; Caron FJ; Schoemaker J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1126-32. PubMed ID: 3932449
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
8. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.
Lobo RA; Granger L; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1981 Jan; 52(1):156-8. PubMed ID: 6778890
[TBL] [Abstract][Full Text] [Related]
9. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
10. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
12. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.
Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407
[TBL] [Abstract][Full Text] [Related]
13. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
[TBL] [Abstract][Full Text] [Related]
14. Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
Anttila L; Koskinen P; Kaihola HL; Erkkola R; Irjala K; Ruutiainen K
Fertil Steril; 1992 Oct; 58(4):697-702. PubMed ID: 1426312
[TBL] [Abstract][Full Text] [Related]
15. The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome.
Mehta RV; Malcom PJ; Chang RJ
J Clin Endocrinol Metab; 2006 Sep; 91(9):3503-6. PubMed ID: 16804036
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
Anttila L; Ding YQ; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
[TBL] [Abstract][Full Text] [Related]
17. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.
Okon MA; Laird SM; Tuckerman EM; Li TC
Fertil Steril; 1998 Apr; 69(4):682-90. PubMed ID: 9548158
[TBL] [Abstract][Full Text] [Related]
18. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
[TBL] [Abstract][Full Text] [Related]
19. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
[TBL] [Abstract][Full Text] [Related]
20. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
